UniCredit Put 44 RWE 19.06.2024/ DE000HC3ESW0 /
30/05/2024 19:37:54 | Diferencia-0.010 | Bid21:58:22 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
3.970EUR | -0.25% | 3.960 Volumen de oferta: 4,000 |
- Tamaño/ Volumen/ Formato de Ask: - |
RWE AG INH O.N. | 44.00 - | 19/06/2024 | Put |
GlobeNewswire
22:10
Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
GlobeNewswire
22:10
Kimco Realty® Management to Present at Nareit’s REITweek: 2024 Investor Conference
GlobeNewswire
22:05
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
GlobeNewswire
22:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of P...
GlobeNewswire
22:05
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedr...
GlobeNewswire
22:05
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
GlobeNewswire
22:05
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Stu...
GlobeNewswire
22:05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
22:05
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:05
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
GlobeNewswire
22:05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página